Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (231-240 of 268) with videos related to

Pageof 27
Sort By:
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
Oncogene|December 3, 2013
Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteinsJ R Smith, E de Billy, S Hobbs, et al.
British Journal of Cancer|February 12, 1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554E O Aboagye, R J Maxwell, M R Horsman, et al.
Scientific Reports|October 7, 2020
Robustness of sex-differences in functional connectivity over time in middle-aged marmosetsBenjamin C Nephew, Marcelo Febo, Ryan Cali, et al.
Journal of Chromatography|May 1, 1978
Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatographyP Workman, C J Little, T R Marten, et al.
British Journal of Cancer|May 1, 1986
The in vitro effects and cross-resistance patterns of some novel anthracyclinesP R Twentyman, N E Fox, K A Wright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Cancer Research|August 1, 1990
Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditionsP R Hoban, M I Walton, C N Robson, et al.
Anti-Cancer Drug Design|June 1, 1996
Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitorsV G Brunton, L R Kelland, M J Lear, et al.
The British Journal of Radiology|November 1, 1983
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in manN M Bleehen, R M Grant, D H Jones, et al.
Pageof 27

Showing results (231-240 of 268) with videos related to

Sort By:
Pageof 27
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
Oncogene|December 3, 2013
Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteinsJ R Smith, E de Billy, S Hobbs, et al.
British Journal of Cancer|February 12, 1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554E O Aboagye, R J Maxwell, M R Horsman, et al.
Scientific Reports|October 7, 2020
Robustness of sex-differences in functional connectivity over time in middle-aged marmosetsBenjamin C Nephew, Marcelo Febo, Ryan Cali, et al.
Journal of Chromatography|May 1, 1978
Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatographyP Workman, C J Little, T R Marten, et al.
British Journal of Cancer|May 1, 1986
The in vitro effects and cross-resistance patterns of some novel anthracyclinesP R Twentyman, N E Fox, K A Wright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Cancer Research|August 1, 1990
Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditionsP R Hoban, M I Walton, C N Robson, et al.
Anti-Cancer Drug Design|June 1, 1996
Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitorsV G Brunton, L R Kelland, M J Lear, et al.
The British Journal of Radiology|November 1, 1983
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in manN M Bleehen, R M Grant, D H Jones, et al.
Pageof 27